GNTA Stock Summary and Trading Ideas (Genenta Science S.P.A. - American Depositary Shares | NASDAQ:GNTA)

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Genenta Science S.P.A. - American Depositary Shares trades on the NASDAQ stock market under the symbol GNTA.

As of June 18, 2026, GNTA stock price declined to $1.68 with 114,404 million shares trading.

GNTA has a beta of 1.18, meaning it tends to be more sensitive to market movements. GNTA has a correlation of 0.01 to the broad based SPY ETF.

GNTA has a market cap of $39.37 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, GNTA traded as high as $10.00 and as low as $.55.

GNTA has underperformed the market in the last year with a price return of -46.0% while the SPY ETF gained +26.9%. However, in the short term, GNTA had mixed performance relative to the market. It has outperformed in the last 3 months, returning +143.5% vs +13.5% return in SPY. But in the last 2 weeks, GNTA shares have been beat by the market, returning -14.3% compared to an SPY return of -1.1%.

GNTA support price is $1.62 and resistance is $2.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GNTA shares will trade within this expected range on the day.